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Mycoplasma hyopneumoniae is the etiologic agent of porcine enzootic pneumonia, responsible for 
major production losses worldwide. The bacteria have a limited metabolism and need to obtain 
molecules from the growth environment, which causes multiple difficulties for in vitro culture. These 
limitations have a negative influence on the ability to carry out research for the development of the 
rational use of antimicrobials and vaccines. The objective of this investigation was to evaluate the 
genetic profile and in vitro susceptibility of field isolates of M. hyopneumoniae to different 
antimicrobials. All 16 isolates obtained from the samples presented 100% of identity in the partial 
sequence of 16S rRNA gene when compared to M. hyopneumoniae. A dendrogram was created 
using the PCR results of the genes related to pathogenicity, and the isolates were distributed into four 
clusters, suggesting genetic variability among four different isolates circulating on the same farm. 
The minimum inhibitory concentration of the isolates was higher for the antimicrobials tylosin (< 
0.001–16 mg/L) and spiramycin (< 0.001–16 mg/L) than for enrofloxacin (< 0.001–0.125 mg/L) and 
tiamulin (< 0.001–0.125 mg/L). Our results demonstrate the genetic variability among M. 
hyopneumoniae isolates from pigs of the same farm, with differences in their susceptibility to 
antimicrobial agents. 
 






1.  Introduction. 
Brazil, as a substantial producer of pork meat, is the fourth largest producer and exporter of this 
product in the world [1] and has highly skilled pig breeding and varied production systems. The 
Brazilian pork industry consists of small independent producers, regional companies, or vertically 
integrated production complexes that cater to internal and external markets [2].  
 
Respiratory diseases are the most important health problems associated with pig production. 
Enzootic pneumonia is a highly contagious chronic respiratory disease of pigs, caused by 
Mycoplasma hyopneumoniae. This disease is characterized by dry cough, delayed growth, poor feed 
conversion, and a predisposition to other pulmonary infections [3, 4]. The clinical manifestations 
associated with the agent have been frequent and common in the main producing regions of the 
country, which lead to a decrease in productivity and significant economic losses [5].  
 
M. hyopneumoniae has few biosynthetic pathways. The lack of biosynthetic pathways implies that 
the bacteria need to obtain amino acids, purines, pyrimidines, and components of the cell membrane 
from the growth environment. These needs show a complex nutritional requirement and dependence 
on the host. These characteristics explain the great difficulty of in vitro M. hyopneumoniae culture 
[6, 7]. Due to the fastidious nature of M. hyopneumoniae, only a few laboratories are capable of 
performing isolation and susceptibility tests on antimicrobial molecules [7]. Even international 
reference guides, such as the Clinical and Laboratory Standards Institute (CLSI), which sets 
standards for antimicrobial susceptibility testing, do not provide information on Mycoplasma species 
of veterinary importance, making it difficult to evaluate results and leading to a lack of consensus 
among researchers.  
 
Therefore, to be able to evaluate the antimicrobial susceptibility of field isolates of M. 
hyopneumoniae, the ability to monitor antimicrobial resistance and implement more efficient 
medication programs in Brazil is essential. This work is the first study carried out with M. 
hyopneumoniae Brazilian field isolates and aims to understand the genetic profile and evaluate in 
vitro susceptibility to the main classes of antimicrobials. 
 
 
2. Materials and Methods  
Samples and M. hyopneumoniae isolation 
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Lung samples from pigs with lesions suggestive of enzootic pneumonia were collected in November 
2017, from a slaughterhouse located at Vale do Piranga in the region of Zona da Mata, Minas Gerais 
State, Brazil, which is an important region of swine production. The samples were from the same 
batch and farm.  
 
The affected lung fragments were sectioned into fragments of ± 10 cm2 , macerated, and added to a 
tube containing liquid medium; the medium used was Friis 1x and 2.8 [8]. After membrane filtration 
(porosity: 0.45 μm) and serial dilutions of the contents, the tubes were kept in an incubator at 37 °C 
and observed daily for 30 days. Color changes of the liquid medium evidenced bacterial growth. The 
samples were submitted to DNA extraction and PCR for confirmation, and the positive samples were 
maintained at− 80 °C. 
 
PCR and DNA Sequencing 
The samples were submitted to PCR to confirm the presence of M. hyopneumoniae. An additional 
PCR was used for the detection of M. hyorhinis and M. flocculare, which present faster growth in 
Friis medium and could inhibit the growth of M. hyopneumoniae [9]. DNA extraction from the 
samples was performed with phenol-chloroform [10], and PCR was performed using primers to the 
16S ribosomal RNA gene of M. hyopneumoniae that amplify a partial sequence between regions V2 
and V4 [11]. For M. hyorhinis PCR, we used the protocol described by Stakenborg et al. [12], and 
the protocol we used for M. flocculare PCR was based on Stemke [13].  
 
All reactions were performed in a thermocycler and composed of 12.5 μL of Go Taq Green Master 
Mix 2x PCR kit (Promega Corporation). PCR products from each sample were purified using 0.8% 
agarose gel with the “GFX™ PCR DNA and Gel Band Purification” kit and sent for sequencing at 
Myleus Biotechnology. The samples were sequenced by capillary electrophoresis in the ABI3730 
apparatus using POP7 and BigDye v3.1 polymer. The generated sequences were aligned and edited 
using CLC Main Workbench 6.7.1 (CLC Bio), then compared to sequences already deposited in 
GenBank using BLAST software. 
 
Mycoplasma hyopneumoniae genetic profile 
The genetic profile of the isolated samples was applied to PCR, directed to the M. hyopneumoniae 
genes involved with mechanisms of virulence or immune response. The primers used for PCR assays 
are described in Table A.1 [14, 15]. The results obtained in the PCR were analyzed by BioNumerics 
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(version 6.6.11-Applied Maths NV, SintMartens-Latem, Belgium), with the following similarity 
parameters: Dice correlation, with a cutoff value of 100% similarity and applying the unweighted 
paired group method with the arithmetic mean (UPGMA). 
 
Antimicrobial susceptibility testing 
The antimicrobial susceptibility test was performed using the microbroth dilution method to 
determine the minimum inhibitory concentration (MIC) [16]. Antimicrobials belonging to Braz J 
Microbiol the three most commonly used classes to control infection in vivo, and that were available 
for delivery in the Brazilian market, were selected. Therefore, the following antimicrobials were 
chosen: tylosin and spiramycin (macrolides), tiamulin (pleuromutilins), and enrofloxacin 
(fluoroquinolones), all of which originated from Sigma Aldrich, Brazil.  
 
The isolates of M. hyopneumoniae had a count between 103 and 105 CCU/mL, assessed using the 
microbroth dilution method [17]. Stock solutions were prepared in sterile distilled water and stored 
at− 20 °C. Sixteen dilutions of the antibiotics were performed, ranging from 0.001 to 64 mg/L. The 
microbroth dilution test was performed using a 96-well plate. Previously, 100 μL(103 –105 
CCU/mL) of the culture was added to the plate and incubated for at least 1 h. All plates had a 
positive control (culture without antibiotic) and negative control (modified Friis medium). After 1 h 
of incubation, 100 μL of the antibiotic at each concentration (0.001–64 mg/L) was added to the 
wells. The plates were then sealed and incubated at 37°C for 21 days. The plates were monitored 
daily for any color change in the wells. The MIC was established as the lowest antibiotic 
concentration at which there was no color change in the medium, characterized by no bacterial 
growth. 
 
3. Results  
Isolation and Mycoplasma hyopneumoniae culture 
Sixteen isolates of M. hyopneumoniae were obtained. After three days, acidification of the culture 
was observed in some samples, characterizing bacterial grow thin of the Friis modified medium. In 
the solid culture medium, diverse types of colonies and growth times were observed under a 
stereoscopic microscope. The morphology of the M. hyopneumoniae colonies varied from circular to 
oval and irregular. Moreover, it was small to large, smooth to rough, pale to stained, and single or in 
combination (Fig. 1).  
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Identification and partial sequencing 
PCR, which amplified a 649-base pair fragment of 16S rRNA gene, was performed to identify the 
isolates. All samples were positive for M. hyopneumoniae , and only one sample was positive for M. 
hyopneumoniae and M. flocculare. All isolates for M. hyopneumoniae were purified in solid 
medium. After the second inoculation in a solid medium, there was no more contamination for M. 
flocculare.  
 
The results of the M. hyopneumoniae16S partial gene alignment showed that the samples had 100% 
identity, compared to other isolates deposited into GenBank.  
 
Genetic profile of Mycoplasma hyopneumoniae isolates  
The presence or absence of genes involved with pathogenicity was evaluated. The genes mhp0461, 
mhp0272, mhp0487, mhp0107, mhp0660, mhp372, mhp199, mhp0443, p42, p97, and p46 were 
present in 100% of the isolates. To NrdF, p95, mnuA, and mhp418 genes, the positivity rate was 
93%, and for p37, it was 81.25%. Figure 2 shows that the isolate named “O” did not have the 
mhp418, p37, mnuA, and NrdF genes. There was an absence of the gene that encodes P37 protein in 
isolates “N” and “P”. Only isolate “I” was negative for the gene encoding the P95 lipoprotein. In the 
evaluation of the gene distribution among the isolates (Fig. 2a), the isolates were classified into four 
different genogroups (Fig. 2b). The isolate “O” had the greatest genetic distance, compared to the 
other isolates, and it was negative for three of the 16 genes tested.  
 
Minimal inhibitory concentration  
The values for the antimicrobial susceptibility of M. hyopneumoniae are presented as MICrange, 
MIC50, and MIC90. Table 1 presents the comparative results between this study and other research. 
For tylosin and spiramycin, a similar range of MIC was found, with values < 0.001 to 16 mg/L. The 
enrofloxacin and tiamulin MIC values ranged from < 0.001 to 0.125 mg/L. Regarding the 
MIC50/MIC90 ratios, tylosin showed values of 0.125/16 mg/L, whereas spiramycin had values of 
0.5/16 mg/L. Enrofloxacin and tiamulin had a proportion of 0.003/0.125 mg/L and < 0.001/0.125 
mg/L, respectively. The analyses of the MIC range values (Table 1) showed a wide range of 
distribution for all tested antimicrobials, mainly for tylosin and spiramycin; antimicrobial 
susceptibility values for 90% of the isolates were the highest values for these two antimicrobials. For 
enrofloxacin, a low MIC50 value was obtained. The lowest inhibitory concentration for 50 and 90% 
of the isolates was observed for tiamulin. 
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4.  Discussion  
This work characterized 16 isolates of M. hyopneumoniae from lung samples with lesions suggestive 
of enzootic pneumonia from a single pig farm. The medium for culture, developed by Cook et al. [8], 
proved to be efficient for the growth of M. hyopneumoniae. M. hyopneumoniaeisolates were 
genetically characterized, and the antimicrobial resistance was evaluated. The partial sequence of 
16S ribosomal RNA gene analyses showed 100% identity among the J, 232, 7448, 7442, and 168 
strains. After alignment and comparison with other isolates deposited into GenBank, it could be 
observed that there was no variation. Therefore, the sequences are highly conserved for the 16S gene 
in M. hyopneumoniaeisolates. Ribosomal RNA (rRNA) genes have been used worldwide to establish 
phylogeny because they are present in all cells and maintain high identity in conserved regions [18]. 
 
Figure 2 shows the isolates that were grouped into four clusters based on the presence or absence of 
genes encoding proteins involved with the pathogenicity of the bacterium. Two isolates did not have 
the gene that encodes P37 protein. One isolate did not have the gene p95 lipoprotein-related protein. 
The isolate called “O” did not have the mhp418, p37, mnuA, and NrdF genes. Results indicate the 
presence of at least four different M. hyopneumoniae isolates within the same farm. Other studies 
have also shown that different strains of M. hyopneumoniae can circulate on the same farm [19, 20].  
 
P37 protein is characterized as an ABC transporter or ATPbinding cassette, one of the major carrier 
families. It is located on the plasma membrane and binds and hydrolyzes adenosine triphosphate 
(ATP), providing energy for nutrient absorption. ABC transporters have already demonstrated 
immunogenic properties stimulating specific immune responses, and they may be related to 
pathogenesis in some species of mycoplasma [21]. It is believed that most lipoproteins, as well as 
P95, are exposed to the extracellular environment and can perform various functions, such as 
adhesion, signal transduction, and nutrient transport [22].  
 
The mnuA nuclease is considered a surface virulence factor. Virginio et al. [23] demonstrated that 
mnuA induced a strong humoral immune response when IgG was tested in the murine model; it was 
shown to be a strong immunogenic antigen as it significantly stimulated high levels of interferon-
gamma and increased the amount of interleukin-10. When evaluating the antigenicity of proteins 
secreted by M. hyopneumoniae, mhp418 was recognized in serum from swine that were naturally 
infected by the agent [24]. The obtained results, with the presence of isolates from the same batch of 
animals belonging to four different genetic groups, demonstrated the possible genetic diversity of M. 
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hyopneumoniae strains within the same batch, farm, city, and region, as has been also observed in 
other genetic diversity studies [20, 25].  
 
Antimicrobial resistance tests were carried out under routine pig management. The use of antibiotics, 
despite all its peculiarities and resistance reports, continues to be of great importance since 
vaccination alone is not able to inhibit the colonization of M. hyopneumoniae in the respiratory tract. 
Therefore, the treatment of infected herds with antibiotics is frequently used as an alternative or in a 
complementary manner to vaccines, to improve clinical signs and pig performance [26, 27]. 
Regarding the evaluation of antimicrobial susceptibility, although the M. hyopneumoniae isolates 
used in this study came from the same farm and may not represent the population of the bacteria in 
Brazil, our study performed, for the first time, the evaluation of antimicrobial susceptibility using 
field samples.  
 
We compared the minimum inhibitory concentrations of antimicrobials that were obtained in this 
study with several authors (Table 1) because the reference guide (CLSI) does not list cutoff values 
for M. hyopneumoniae. Tavío et al. [27] found a MICrange for tylosin and spiramycin in isolates from 
Spain that was consistent with the values of < 0.001 to 16 mg/L, different from that observed by 
Klein et al. [16], who obtained much smaller values. For enrofloxacin and tiamulin, Klein et al. [16] 
found MIC50 values of 0.0031 mg/L and 0.0016 mg/L, respectively, with concentrations similar to 
those found in our work.  
 
The rate of change for the MIC obtained by the cited authors [16, 27, 28] was generally 0.008–25 
mg/L for enrofloxacin and 0.002–0.78 mg/L for tiamulin. The present study demonstrated rates 
below < 0.001–0.125 mg/L for both antimicrobials and the lowest inhibitory concentration for 90% 
of the isolates for enrofloxacin (Table 1). The MIC90 values for tiamulin were similar to those 
obtained in other studies [27–29].  
 
A recent study showed the susceptibility of field isolates of M. hyopneumoniae from Central Europe, 
and, in comparison with the results obtained from our work, the MIC range for tylosin was even 
higher, with a maximum limit of 64 μg/mL, than that obtained in this study, which was 16 mg/L 
[26]. A large divergence, in comparison with these results, was found in a 1993 study in which 25 
isolates were evaluated for susceptibility to tylosin: 100% of the isolates had MIC values ≤ 0.125, 
with the exception of strain 232, with a MIC of 0.25 μg/mL [30].  
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Analyzing these results and those obtained in our study, there is a decrease in the susceptibility of M. 
hyopneumoniae over time, with the need to increase concentrations to inhibit the growth of M. 
hyopneumoniae, demonstrating resistance; this occurrence is more pronounced for the macrolides 
(tylosin and spiramycin), followed by the fluoroquinolones (enrofloxacin). MICs did not exceed 0.3 
μg/mL for pleuromutilins (tiamulin), which have been shown to have a better effect in vitro, with 
low inhibitory concentrations, corroborating with the results obtained by other authors [7, 16, 27, 
28].  
 
Sensitive, resistant, or intermediate designations are common to almost all laboratory-testing 
methods and are distinguishable using breakpoints of antibiotic concentrations. However, these 
factors have not been determined for mycoplasma infections, owing to the variety of hosts that can 
cause disease and because there is little available pharmacological data [17].  
 
The highest level of inhibitory concentrations of the major veterinary Mycoplasma species was 
observed for macrolides. Although resistant strains have been described for fluoroquinolones, most 
strains remain susceptible to this family of antibiotics. Pleuromutilins are the most effective 
antibiotics in vitro [7]. Fluoroquinolones are antimicrobial agents that are potentially active against 
M. hyopneumoniae through the inhibition of the enzyme DNA gyrase and topoisomerase IV [26]. In 
the present study, a low MIC50 value was recorded for enrofloxacin, similar to other results [16, 27, 
28]; however, this was different from the level found by Thongkamkoon et al. [29], who obtained 
MIC50 values above 1.56 μg/mL. According to the results obtained by Felde et al. [26], and in 
agreement with the results of this work, pleuromutilins remain the most effective antimicrobial 
against M. hyopneumoniae because they have a low inhibitory concentration in vitro.  
 
It has already been observed that strains of the same herd can show different DNA sequences. Based 
on genotyping analyses, Felde et al. [26] showed different susceptibility profiles and genetic 
alterations correlated with this antimicrobial susceptibility. The results of this study were consistent 
with those of Felde et al. [26]. The isolates that presented different genetic profiles showed 
differences in their susceptibility to the antimicrobials tylosin, spiramycin, enrofloxacin, and 
tiamulin.  
 
MIC values are not necessarily correlated with antimicrobial efficacy in vivo, and the interpretation 
of MIC distributions is difficult because Mycoplasma species with veterinary relevance do not have 
official clinical breakpoints. In addition, strains with different susceptibilities to antibiotics may 
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coexist within a herd [26]. However, the obtained results can help veterinarians make decisions 
about which antimicrobial agent to choose, thus performing a more targeted treatment. It is important 
to note that, unlike most studies that are carried out with classical strains that were isolated decades 
ago, this study evaluated susceptibility in recently obtained isolates from the lungs with lesions of 
enzootic pneumonia.  
 
Based on the results of this study, high minimum inhibitory concentrations were found for some 
isolates in relation to the antimicrobials tylosin and spiramycin. Authorities from various countries, 
such as the World Health Organization (WHO) and the Food and Agriculture Organization of the 
United Nations (FAO), have been working to reduce the use of these molecules, mainly their use as 
additives to improve performance. In this sense, the Ministry of Agriculture, Livestock, and Supply 
(MAPA) from Brazil has also taken some measures to reduce the use of antimicrobials, such as IN 
14/2016 and Ordinance 171/2018, which created more rigid criteria for the handling and use of 
veterinary drugs in production animal feed, and Order 171/2018, which outlines the intention to ban 
the use of antimicrobials as additives for the purpose of performance enhancement.  
 
Due to different antimicrobial handling and use practices, resistance frequencies can vary 
considerably from one country to another but also within the same country with isolates of different 
origins and farms from the same country’s region. About the protocol of antimicrobial treatment 
performed on the farm, we did not had access to this information because the samples were not 
collected from the farm but from the slaughterhouse certified by the Brazilian official inspection 
service (MAPA). However, if we had access to the antimicrobial protocol used by farm, it could 
improve the results’ discussion herein presented. 
 
Conclusion 
The Mycoplasma hyopneumoniae field strains isolated in our study showed variations in the NrdF, 
p95, mnuA, mhp418, p42, and p37 genes, which could be possibly involved in the pathogenesis of 
the bacteria, giving rise to at least four different genetic groups. The MIC determination assay 
showed lower inhibitory concentrations for enrofloxacin and tiamulin than for spiramycin and 
tylosin. There was a wide range of variation among isolates, showing the importance of constant 
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Table 1.    Minimum inhibitory concentration (MIC) of four antimicrobial agents tested for different 
Mycoplasma hyopneumoniae isolates 
References Antimicrobials 
 Tylosin Espiramicin Enrofloxacin Tiamulin 
 MICrange MIC50 MIC90 MICrange MIC50 MIC90 MICrange MIC50 MIC90 MICrange MIC50 MIC90 
              [*]1 
< 0.001–
16 0.125 16 
< 0.001–
16 0.5 16 
< 0.001–
0.125 0.003 0.125 
< 0.001–
0.125 <0.001 0.125 
182 0.008-16 0.006 0.25 0,03-16 0.25 0.5 0.03-1 0.125 1 
0.03–
0.125 0.06 0.125 
161 
0.004–
0.25 0.0031 0.125 
0,008–
0.5  0.062 0.25 0.008-1 0.0031 0.5 
0.002–
0.125 0.0016 0.062 
192 
≤ 0.025–
> 12.5 0.1 0.39 0.1-25 0.39 0.78 0.1-25 1.56 6.25 
≤ 0.013–
0.78 0.05 0.1 
202 
≤ 0.015–
> 1 0.06 0.12 NR NR NR 0.03 > 1 0.06 0.5 
≤ 0.015–
0.12 0.03 0.12 
212 0.25–64 0.5 0.5 NR NR NR 0.039-5 0.312 2.5 
0.078-
0.312 0.156 0.156 
222 
≤ 0.125–







Figure 1. Colonies of Mycoplasma hyopneumoniae field isolates (EVOS XL Core, magnification 




Figure 2. Genetic profile showing the four genogroups of Mycoplasma hyopneumoniae positive samples 
(BioNumerics software). a Dendrogram that shows the presence and absence of tested genes in each isolate. b 
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